Participants' and Nurses' Experiences With a Digital Intervention for Patients With Depressive Symptoms and Comorbid Hypertension or Diabetes in Peru: Qualitative Post-Randomized Controlled Trial Study.
comorbidity
depression
diabetes
hypertension
mobile intervention
mobile phone
qualitative research
Journal
JMIR human factors
ISSN: 2292-9495
Titre abrégé: JMIR Hum Factors
Pays: Canada
ID NLM: 101666561
Informations de publication
Date de publication:
15 Sep 2022
15 Sep 2022
Historique:
received:
23
12
2021
accepted:
18
07
2022
revised:
08
07
2022
entrez:
15
9
2022
pubmed:
16
9
2022
medline:
16
9
2022
Statut:
epublish
Résumé
Depression is one of the most prevalent mental disorders and a leading cause of disability, disproportionately affecting specific groups, such as patients with noncommunicable diseases. Over the past decade, digital interventions have been developed to provide treatment for these patients. CONEMO (Emotional Control in Spanish) is an 18-session psychoeducational digital intervention delivered through a smartphone app and minimally supported by a nurse. CONEMO demonstrated effectiveness in reducing depressive symptoms through a randomized controlled trial (RCT) among patients with diabetes, hypertension, or both, in Lima, Peru. However, in addition to clinical outcomes, it is important to explore users' experiences, satisfaction, and perceptions of usability and acceptability, which can affect their engagement with the intervention. This study aimed to explore the RCT participants' experiences with CONEMO in Peru, complemented with information provided by the nurses who monitored them. In 2018, semistructured interviews were conducted with a sample of 29 (13.4%) patients from the 217 patients who participated in the CONEMO intervention in Peru and the 3 hired nurses who supported its delivery. Interviewees were selected at random based on their adherence to the digital intervention (0-5, 10-14, and 15-18 sessions completed), to include different points of view. Content analysis was conducted to analyze the interviews. Participants' mean age was 64.4 (SD 8.5) years, and 79% (23/29) of them were women. Most of the interviewed participants (21/29, 72%) stated that CONEMO fulfilled their expectations and identified positive changes in their physical and mental health after using it. Some of these improvements were related to their thoughts and feelings (eg, think differently, be more optimistic, and feel calmer), whereas others were related to their routines (eg, go out more and improve health-related habits). Most participants (19/29, 66%) reported not having previous experience with using smartphones, and despite experiencing some initial difficulties, they managed to use CONEMO. The most valued features of the app were the videos and activities proposed for the participant to perform. Most participants (27/29, 93%) had a good opinion about the study nurses and reported feeling supported by them. A few participants provided suggestions to improve the intervention, which included adding more videos, making the sessions' text simple, extending the length of the intervention, and improving the training session with long explanations. The findings of this qualitative study provide further support and contextualize the positive results found in the CONEMO RCT, including insights into the key features that made the intervention effective and engaging. The participants' experience with the smartphone and CONEMO app reveal that it is feasible to be used by people with little knowledge of technology. In addition, the study identified suggestions to improve the CONEMO intervention for its future scale-up. ClinicalTrials.gov NCT03026426; https://clinicaltrials.gov/ct2/show/NCT03026426.
Sections du résumé
BACKGROUND
BACKGROUND
Depression is one of the most prevalent mental disorders and a leading cause of disability, disproportionately affecting specific groups, such as patients with noncommunicable diseases. Over the past decade, digital interventions have been developed to provide treatment for these patients. CONEMO (Emotional Control in Spanish) is an 18-session psychoeducational digital intervention delivered through a smartphone app and minimally supported by a nurse. CONEMO demonstrated effectiveness in reducing depressive symptoms through a randomized controlled trial (RCT) among patients with diabetes, hypertension, or both, in Lima, Peru. However, in addition to clinical outcomes, it is important to explore users' experiences, satisfaction, and perceptions of usability and acceptability, which can affect their engagement with the intervention.
OBJECTIVE
OBJECTIVE
This study aimed to explore the RCT participants' experiences with CONEMO in Peru, complemented with information provided by the nurses who monitored them.
METHODS
METHODS
In 2018, semistructured interviews were conducted with a sample of 29 (13.4%) patients from the 217 patients who participated in the CONEMO intervention in Peru and the 3 hired nurses who supported its delivery. Interviewees were selected at random based on their adherence to the digital intervention (0-5, 10-14, and 15-18 sessions completed), to include different points of view. Content analysis was conducted to analyze the interviews.
RESULTS
RESULTS
Participants' mean age was 64.4 (SD 8.5) years, and 79% (23/29) of them were women. Most of the interviewed participants (21/29, 72%) stated that CONEMO fulfilled their expectations and identified positive changes in their physical and mental health after using it. Some of these improvements were related to their thoughts and feelings (eg, think differently, be more optimistic, and feel calmer), whereas others were related to their routines (eg, go out more and improve health-related habits). Most participants (19/29, 66%) reported not having previous experience with using smartphones, and despite experiencing some initial difficulties, they managed to use CONEMO. The most valued features of the app were the videos and activities proposed for the participant to perform. Most participants (27/29, 93%) had a good opinion about the study nurses and reported feeling supported by them. A few participants provided suggestions to improve the intervention, which included adding more videos, making the sessions' text simple, extending the length of the intervention, and improving the training session with long explanations.
CONCLUSIONS
CONCLUSIONS
The findings of this qualitative study provide further support and contextualize the positive results found in the CONEMO RCT, including insights into the key features that made the intervention effective and engaging. The participants' experience with the smartphone and CONEMO app reveal that it is feasible to be used by people with little knowledge of technology. In addition, the study identified suggestions to improve the CONEMO intervention for its future scale-up.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov NCT03026426; https://clinicaltrials.gov/ct2/show/NCT03026426.
Identifiants
pubmed: 36107482
pii: v9i3e35486
doi: 10.2196/35486
pmc: PMC9523528
doi:
Banques de données
ClinicalTrials.gov
['NCT03026426']
Types de publication
Journal Article
Langues
eng
Pagination
e35486Informations de copyright
©Mauricio Toyama, Victoria Cavero, Ricardo Araya, Paulo Rossi Menezes, David C Mohr, J Jaime Miranda, Francisco Diez-Canseco. Originally published in JMIR Human Factors (https://humanfactors.jmir.org), 15.09.2022.
Références
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Transl Behav Med. 2017 Jun;7(2):254-267
pubmed: 27966189
Int J Health Policy Manag. 2017 Jan 22;6(9):501-508
pubmed: 28949462
J Med Internet Res. 2019 Jul 22;21(7):e12869
pubmed: 31333198
Lancet Psychiatry. 2017 Feb;4(2):90-92
pubmed: 28137383
Med J Aust. 2010 Jun 7;192(S11):S4-11
pubmed: 20528707
PLoS One. 2014 Jun 17;9(6):e100100
pubmed: 24936656
Med Devices (Auckl). 2020 Feb 11;13:31-39
pubmed: 32104106
JMIR Ment Health. 2019 Apr 26;6(4):e11698
pubmed: 31025949
JMIR Ment Health. 2020 Jun 19;7(6):e16730
pubmed: 32558659
Stud Health Technol Inform. 2016;228:190-4
pubmed: 27577369
Am J Trop Med Hyg. 2021 May 17;105(1):6-11
pubmed: 33999847
Evid Based Ment Health. 2018 Aug;21(3):116-119
pubmed: 29871870
JMIR Mhealth Uhealth. 2019 Jan 30;7(1):e11325
pubmed: 30698535
World Psychiatry. 2017 Oct;16(3):287-298
pubmed: 28941113
Lancet Psychiatry. 2020 Oct;7(10):851-864
pubmed: 32866459
J Med Syst. 2015 Feb;39(2):1
pubmed: 25600193
Rev Panam Salud Publica. 2018 Oct 10;42:e165
pubmed: 31093193
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Clin Psychol Rev. 2012 Jun;32(4):329-42
pubmed: 22466510
Gerontology. 2016;62(4):443-9
pubmed: 26539997
Nat Rev Dis Primers. 2020 Aug 20;6(1):69
pubmed: 32820163
J Med Internet Res. 2012 Jun 22;14(3):e91
pubmed: 22743581
BMC Health Serv Res. 2016 Sep 05;16 Suppl 5:290
pubmed: 27608677
Nicotine Tob Res. 2016 May;18(5):1032-8
pubmed: 26581430
J Prim Prev. 2012 Jun;33(2-3):137-52
pubmed: 22766606
Discov Ment Health. 2022;2(1):12
pubmed: 35677652
Epidemiol Psychiatr Sci. 2015 Jun;24(3):233-40
pubmed: 25833714
Hum Resour Health. 2021 Feb 5;19(1):16
pubmed: 33546709
JAMA. 2021 May 11;325(18):1852-1862
pubmed: 33974019
Exp Gerontol. 2019 Jun;120:68-87
pubmed: 30836130